Nccn Grants Funding To Five Oncology Leaders Of The Future

The National Comprehensive Cancer Network® (NCCN®)-an confederation of starring crab centers-announces nan 2026 recipients for nan yearly NCCN Foundation® Young Investigator Awards. The awards assistance early profession investigators backing to beforehand investigation connected important issues successful oncology. The recipients were selected by nan NCCN Oncology Research Program (ORP), which will supply oversight and guidance crossed nan two-year program.

"We person a rigorous adjacent reappraisal process for identifying emerging leaders successful crab investigation done their work," said Crystal S. Denlinger, MD, CEO, NCCN. "NCCN Young Investigators spell connected to lead wrong their institutions and nationally. This year's recipients identified peculiarly pressing needs that effect group pinch cancer. They are exploring solutions to unlock amended outcomes for each successful nan future. We are honored to play a domiciled successful their profession trajectory and look guardant to seeing wherever it takes them."

The 2026 NCCN Foundation Young Investigator Awardees are:

• Monica F. Chen, MD, Memorial Sloan Kettering Cancer Center
  • CXCR2 Inhibition Combined pinch Proton Craniospinal Irradiation for Patients pinch Melanoma and Leptomeningeal Disease

• Yang Chen, PhD, The University of Texas MD Anderson Cancer Center
  • Targeting Fibroinflammation to Prevent Resistance to KRAS Inhibition successful Pancreatic Cancer

• Scott Furlan, MD, Fred Hutchinson Cancer Center
  • Residual Disease, Revealed: Defining Age-Specific and Shared Stem-Like Programs Driving Relapse successful AML

• Emily L. Podany, MD, MPHS, Siteman Cancer Center astatine Barnes-Jewish Hospital and WashU Medicine
  • From Screening to Action: Implementing Navigation Interventions for Patients pinch Breast Cancer and High-Risk Social Determinants of Health

• Satoru Osuka, MD, PhD, O'Neal Comprehensive Cancer Center astatine UAB
  • Tumor-Matrix-Binding TGF-β scFv to Suppress TGF-β Signaling successful Recurrent Glioblastoma

Congratulations to this year's exceptional group of awardees. We spot tremendous imaginable successful each of these early-career researchers and their chosen projects. This is arsenic overmuch an finance successful their ideas arsenic it is successful them, arsenic we are committed to building early leaders. Our database of noteworthy past recipients includes NCCN's CEO, Dr. Denlinger, on pinch galore different precocious achievers serving our ngo of defining and advancing high-quality crab prevention and care."

Patrick Delaney, Executive Director, NCCN Foundation

This year's awards were made imaginable done backing from nan NCCN Foundation pinch support from Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo; Edith C. Blum Foundation; Exelixis, Inc.; Merck & Co., Inc.; and Pfizer Inc.

The NCCN Foundation Young Investigator Awards programme began 15 years ago, arsenic an effort to grant and support promising up-and-coming researchers successful oncology. The awards thief fortify nan pipeline for early successes successful nan conflict against cancer. Past awardees precocious presented their findings during nan NCCN 2026 Annual Conference; this year's awardees will coming their activity during nan NCCN 2029 Annual Conference.